Petrie-Flom Center Open House: Health Law, Biotechnology, and the Future
September 19, 2024
5:00 pm - 7:30 pm
This event has passed
RSVP
This event is open to HUID holders only. Please RSVP to receive the location, which will be sent both one week and one day prior to the event.
Event Description
Are you interested in health law and health policy topics?
You’re invited to the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics’ 2024 Open House.
The Petrie-Flom Center is an interdisciplinary research program at Harvard Law School dedicated to scholarly research at the intersection of law and health policy. For our 20th anniversary year we are focused on artificial intelligence in health care, biomedical research and biotechnology, the law and policy of psychedelic medicine, genetics and genomics, global health, reproductive health, law and aging, bioethics, and regulation.
Join us on September 19th at 5:00PM for a panel discussion with top experts in cutting-edge biotechnology and related legal and ethical issues. Meet Center Leadership, learn about our research projects, opportunities for students, Bill of Health blog, and events. We hope to see you there. Light food and drink will be provided.
Panelists
- Co-Moderator: I. Glenn Cohen, Faculty Director, Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics and James A. Attwood and Leslie Williams Professor of Law, and Deputy Dean, Harvard Law School
- Co-Moderator: Leonard Pickard, Affiliated Researcher, Project on Psychedelics Law and Regulation
- Ruth L. Okediji, Jeremiah Smith. Jr, Professor of Law at Harvard Law School and Co-Director of the Berkman Klein Center
- George Church, Founding Core Faculty & Lead, Synthetic Biology Wyss Institute at Harvard University, Professor of Genetics at Harvard Medical School and Professor of Health Sciences and Technology at Harvard and the Massachusetts Institute of Technology (MIT), Director of the U.S. Department of Energy Technology Center and Director of the National Institutes of Health Center of Excellence in Genomic Science
- Tina Liu, Corporate Strategy, Thermo Fisher Scientific; Former CEO and Cofounder, Skylark Bio and Ally Therapeutics
- Alex Zhavoronkov, Founder and CEO of Insilico Medicine